Long term survival with thoracoscopic versus open lobectomy: Propensity matched comparative analysis using seer-medicare database

BMJ (Online)

Volumn 349, Issue , 2014, Pages

  Paul, Subroto ^a   Isaacs, Abby J ^a   Treasure, Tom ^b   Altorki, Nasser K ^a   Sedrakyan, Art ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; ATELECTASIS; CANCER REGISTRY; CANCER SPECIFIC SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HEART ARRHYTHMIA; HUMAN; LONG TERM SURVIVAL; LUNG CANCER; LUNG LOBECTOMY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PNEUMONIA; PROPENSITY SCORE; SEPSIS; THORACOTOMY; VIDEO ASSISTED THORACOSCOPIC SURGERY; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; FACTUAL DATABASE; FOLLOW UP; KAPLAN MEIER METHOD; LUNG NEOPLASMS; LUNG RESECTION; MEDICARE; MORTALITY; PATHOLOGY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL; THORACOSCOPY; TIME; TREATMENT OUTCOME; TUMOR INVASION; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MEDICARE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PNEUMONECTOMY; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL ANALYSIS; THORACOSCOPY; THORACOTOMY; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84907626830     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g5575     Document Type: Article

References (42)

1. National Institute for Health and Clinical Excellence. Lung cancer: the diagnosis and treatment of lung cancer. NICE, 2011.
2. Treasure T, Russell C, Morton D, Macbeth F, Utley M. Surgical resection of lung cancer England: more operations but no trials to test their effectiveness. Thorax2012;67:759-61.
3. Treasure T, Russell C, Morton D, Macbeth F, Utley M. Surgical resection of lung cancer in England: more operations but no trials to test their effectiveness. Thorax 2013;68:187-8.
4. Riaz SP, Luchtenborg M, Jack RH, Coupland VH, Linklater KM, Peake MD, et al. Variation in surgical resection for lung cancer in relation to survival: population-based study in England 2004-2006. Eur J Cancer 2012;48:54-60.
5. Riaz SP, Linklater KM, Page R, Peake MD, Moller H, Luchtenborg M. Recent trends in resection rates among non-small cell lung cancer patients in England. Thorax 2012;67:811-4.
6. Paul S, Sedrakyan A, Chiu YL, Nasar A, Port JL, Lee PC, et al. Outcomes after lobectomy using thoracoscopy vs thoracotomy: a comparative effectiveness analysis utilizing the Nationwide Inpatient Sample database. Eur J Cardiothorac Surg 2013;43:813-7.
7. Paul S, Altorki NK, Sheng S, Lee PC, Harpole DH, Onaitis MW, et al. Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database. J Thorac Cardiovasc Surg 2010;139:366-78.
8. Onaitis MW, Petersen RP, Balderson SS, Toloza E, Burfeind WR, Harpole DH Jr, et al. Thoracoscopic lobectomy is a safe and versatile procedure: experience with 500 consecutive patients. Ann Surg 2006;244:420-5.
9. Nicastri DG, Wisnivesky JP, Litle VR, Yun J, Chin C, Dembitzer FR, et al. Thoracoscopic lobectomy: report on safety, discharge independence, pain, and chemotherapy tolerance. J Thorac Cardiovasc Surg 2008;135:642-7.
10. McKenna RJ Jr, Houck W, Fuller CB. Video-assisted thoracic surgery lobectomy: experience with 1,100 cases. Ann Thorac Surg 2006;81:421-5; discussion 25-6.
11. Lee PC, Nasar A, Port JL, Paul S, Stiles B, Chiu YL, et al. Long-term survival after lobectomy for non-small cell lung cancer by video-assisted thoracic surgery versus thoracotomy. Ann Thorac Surg 2013:96:951-60; discussion 60-1.
12. Flores RM, Park BJ, Dycoco J, Aronova A, Hirth Y, Rizk NP, et al. Lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for lung cancer. J Thorac Cardiovasc Surg 2009;138:11-8.
13. Demmy TL, Curtis JJ. Minimally invasive lobectomy directed toward frail and high-risk patients: a case-control study. Ann Thorac Surg 1999;68:194-200.
14. Cattaneo SM, Park BJ, Wilton AS, Seshan VE, Bains MS, Downey RJ, et al. Use of video-assisted thoracic surgery for lobectomy in the elderly results in fewer complications. Ann Thorac Surg 2008;85:231-5; discussion 35-6.
15. Rich AL, Tata LJ, Free CM, Stanley RA, Peake MD, Baldwin DR, et al. Inequalities in outcomes for non-small cell lung cancer: the influence of clinical characteristics and features of the local lung cancer service. Thorax 2011;66:1078-84.
16. Rich AL, Tata LJ, Stanley RA, Free CM, Peake MD, Baldwin DR, et al. Lung cancer in England: information from the National Lung Cancer Audit (LUCADA). Lung Cancer 2011;72:16-22.
17. Surveillance, Epidemiology and End Results program, http://seer.cancer.gov/index.html.
18. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002;40(8 suppl):IV-3-18.
19. Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials 1996;17:343-6.
20. Lund JL, Sturmer T, Harlan LC, Sanoff HK, Sandler RS, Brookhart MA, et al. Identifying specific chemotherapeutic agents in Medicare data: a validation study. Med Care 2013;51:e27-34.
21. Lardinois D, De Leyn P, Van Schil P, Porta RR, Waller D, Passlick B, et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg 2006;30:787-92.
22. Lardinois D, Suter H, Hakki H, Rousson V, Betticher D, Ris HB. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer. Ann Thorac Surg 2005;80:268-74; discussion 74-5.
23. Shapiro M, Mhango G, Kates M, Weiser TS, Chin C, Swanson SJ, et al. Extent of lymph node resection does not increase perioperative morbidity and mortality after surgery for stage I lung cancer in the elderly. Eur J Surg Oncol 2012;38:516-22.
24. Wang H, D'Amico TA. Efficacy of mediastinal lymph node dissection during thoracoscopic lobectomy. Ann Cardiothorac Surg 2012;1:27-32.
25. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998;36:8-27.
26. Rassen J, Doherty M, Huang W, Schneeweiss S. Using the Pharmacoepi Toolbox in SAS. 2013. www.drugepi.org/wp-content/uploads/2013/10/Using-the-Pharmacoepi-Toolbox-in-SAS-2.4.15.pdf.
27. Austin PC. Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement. J Thorac Cardiovasc Surg 2007;134:1128-35.e3.
28. Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat 2011;10:150-61.
29. Franklin JM, Rassen JA, Ackermann D, Bartels DB, Schneeweiss S. Metrics for covariate balance in cohort studies of causal effects. Stat Med 2013;33:1685-99.
30. Lin DY. Cox regression analysis of multivariate failure time data: the marginal approach. Stat Med 1994;13:2233-47.
31. Licht PB, Jorgensen OD, Ladegaard L, Jakobsen E. A national study of nodal upstaging after thoracoscopic versus open lobectomy for clinical stage I lung cancer. Ann Thorac Surg 2013:96:943-9; discussion 49-50.
32. Su S, Scott WJ, Allen MS, Darling GE, Decker PA, McKenna RJ, et al. Patterns of survival and recurrence after surgical treatment of early stage non-small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial. J Thorac Cardiovasc Surg 2014;147:747-52; discussion 52-3.
33. Botta DJ, Kosinski AS, Paul S, Mitchell JD, Onaitis M. Lymph node evaluation by open or video-assisted approaches in 11,500 anatomic lung cancer resections. Ann Thorac Surg 2012;94:347-53; discussion 53.
34. Coleman MP, Forman D, Bryant H, Butler J, Rachel B, Maringe C, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2011;377:127-38.
35. Belcher JR. Thirty years of surgery for carcinoma of the bronchus. Thorax 1983;38:428-32.
36. National Institute for Health Research. 26th NIHR HTA Clinical Evaluation and Trials Board-decisions from the meeting of 20th and 21 st November 2013. www.nets.nihr.ac.uk/-data/assets/pdf-file/0009/97425/CET-Board-Outcomes-Table-November-2013.pdf.
37. Tieu B, Schipper P. Specialty matters in the treatment of lung cancer. Semin Thorac Cardiovasc Surg 2012;24:99-105.
38. Schipper PH, Diggs BS, Ungerleider RM, Welke KF. The influence of surgeon specialty on outcomes in general thoracic surgery: a national sample 1996 to 2005. Ann Thorac Surg 2009;88:1566-72; discussion 72-3.
39. Cooper MA, Hutfless S, Segev DL, Ibrahim A, Lyu H, Makary MA. Hospital level under-utilization of minimally invasive surgery in the United States: retrospective review. BMJ 2014;349:g4198.
40. Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AM, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 2005:365:1718-26.
41. Kuhry E, Schwenk WF, Gaupset R, Romild U, Bonjer HJ. Long-term results of laparoscopic colorectal cancer resection. Cochrane Database Syst Rev 2008;2:CD003432.
42. Jin LX, Ibrahim AM, Newman NA, Makarov DV, Pronovost PJ, Makary MA. Robotic surgery claims on United States hospital websites. J Healthc Qual 2011;33:48-52.